GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:GS71 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
30 Oct 24	Buy€119,322	Jonathan Symonds	Individual	7,150	€16.69
20 Jun 24	Buy€38,196	Jonathan Symonds	Individual	2,000	€19.10
20 Jun 24	Buy€8,512	Wendy Mira Becker	Individual	446	€19.09
01 Feb 24	Buy€64,388	Jonathan Symonds	Individual	3,500	€18.40
01 Feb 24	Buy€358,921	Julie Brown	Individual	19,360	€18.54
20 Dec 23	Buy€33,397	Jonathan Symonds	Individual	2,000	€16.70
20 Dec 23	Buy€8,005	Urs Rohner	Individual	478	€16.75

Insider Trading Volume

Insider Buying: GS71 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GS71?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,520,254	0.0373%
Individual Insiders	3,469,361	0.085%
State or Government	6,717,427	0.165%
Private Companies	45,842,142	1.12%
Employee Share Scheme	72,477,782	1.78%
General Public	467,033,270	11.4%
Institutions	3,483,439,465	85.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.13%	Dodge & Cox	372,510,492	€6.1b	-0.9%	2.06%
8.48%	BlackRock, Inc.	346,116,839	€5.7b	1.71%	0.1%
4.7%	The Vanguard Group, Inc.	191,755,207	€3.1b	0.53%	0.05%
2.24%	State Street Global Advisors, Inc.	91,492,561	€1.5b	1.22%	0.06%
2.09%	Wellington Management Group LLP	85,113,207	€1.4b	20.1%	0.22%
2.05%	FMR LLC	83,733,483	€1.4b	-3.52%	0.08%
1.98%	Legal & General Investment Management Limited	80,832,617	€1.3b	-3.73%	0.26%
1.98%	Schroder Investment Management Limited	80,779,184	€1.3b	17.1%	0.9%
1.9%	Norges Bank Investment Management	77,390,644	€1.3b	-10.1%	0.11%
1.78%	GlaxoSmithKline Employee Trust	72,477,782	€1.2b	-1.2%	no data
1.63%	UBS Asset Management AG	66,697,894	€1.1b	8.32%	0.12%
1.24%	Mondrian Investment Partners Limited	50,764,058	€831.8m	12%	5.84%
1.2%	Silchester International Investors LLP	49,126,050	€805.0m	-2.54%	3.28%
1.12%	GlaxoSmithKline plc, Shareview Client	45,842,142	€751.2m	-1.97%	no data
1.07%	HSBC Global Asset Management (UK) Limited	43,586,855	€714.2m	-3.5%	0.31%
1.01%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	41,053,198	€672.7m	-1.91%	19.14%
0.95%	Fisher Asset Management, LLC	38,829,470	€636.3m	0.18%	0.28%
0.88%	Aviva Investors Global Services Ltd.	35,767,094	€586.1m	-11.8%	0.8%
0.82%	Columbia Management Investment Advisers, LLC	33,581,146	€550.3m	-15.5%	0.13%
0.78%	Royal London Asset Management Ltd.	31,962,532	€523.7m	8.73%	0.71%
0.74%	Strategic Advisers LLC	30,262,910	€495.9m	-0.18%	0.21%
0.73%	PRIMECAP Management Company	29,707,510	€486.8m	2.36%	0.37%
0.73%	Causeway Capital Management LLC	29,646,365	€485.8m	8.55%	2.22%
0.72%	Franklin Resources, Inc.	29,376,809	€481.4m	-2.6%	0.18%
0.72%	BNY Asset Management	29,268,752	€479.6m	26.6%	0.09%